In today’s recent session, 1.1 million shares of the Xeris Biopharma Holdings Inc (NASDAQ:XERS) have been traded, and its beta is 0.72. Most recently the company’s share price was $4.72, and it changed around $0.32 or 7.27% from the last close, which brings the market valuation of the company to $755.93M. XERS at last check was trading at a discount to its 52-week high of $6.07, offering almost -28.6% off that amount. The share price’s 52-week low was $2.03, which indicates that the recent value has risen by an impressive 56.99% since then.
Xeris Biopharma Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended XERS as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information
Instantly XERS has been showing a green trend so far today with a performance of 7.27% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.79 on recent trading dayincreased the stock’s daily price by 1.46%. The company’s shares are currently up 39.23% year-to-date, but still up 3.74% over the last five days. On the other hand, Xeris Biopharma Holdings Inc (NASDAQ:XERS) is -3.28% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to decrease their stock price by -18.0% from its current value. Analyst projections state that XERS is forecast to be at a low of $4 and a high of $4.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 40.01%.
XERS Dividends
Xeris Biopharma Holdings Inc’s next quarterly earnings report is expected to be released in July.
VANGUARD GROUP INC, with 5.1615% or 7.66 million shares worth $17.23 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
